Literature DB >> 1923365

Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy.

A Yoshida1, M Kojima, H Ogasawara, S Ishiko.   

Abstract

Electroretinography and vitreous fluorophotometry were performed in 36 eyes of 36 noninsulin-dependent diabetic patients and in 32 eyes of 32 healthy control subjects between the ages of 30 and 59 years. Fluorescein fundus angiograms showed no abnormalities in either group. Peak implicit time of the first deflection of the oscillatory potential, interpeak interval between the first and second deflections, and the sum of the amplitudes of the upward deflections were analyzed. Inward permeability of the blood-retinal barrier was calculated by vitreous fluorophotometry and computer simulation. The peak implicit time of the first deflection and the interpeak interval between the first and second deflections of the oscillatory potential were significantly longer in diabetic patients than in control subjects (P less than 0.01). No significant difference in inward permeability of the blood-retinal barrier existed between the two groups. These results indicate that a selective delay in the peak implicit time of the oscillatory potential (neurosensory retinal abnormality) may be present in noninsulin-dependent diabetic patients, representing retinal functional changes before changes in blood-retinal barrier permeability are apparent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1923365     DOI: 10.1016/s0161-6420(91)32144-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  21 in total

Review 1.  A multifocal electroretinogram model predicting the development of diabetic retinopathy.

Authors:  Marcus A Bearse; Anthony J Adams; Ying Han; Marilyn E Schneck; Jason Ng; Kevin Bronson-Castain; Shirin Barez
Journal:  Prog Retin Eye Res       Date:  2006-09-01       Impact factor: 21.198

2.  Long-term full-field and multifocal electroretinographic changes after treatment with ranibizumab in patients with diabetic macular edema.

Authors:  Kenan Yigit; Ümit Übeyt Inan; Sibel Inan; Mustafa Dogan; Guliz Fatma Yavas; Ersan Cetinkaya
Journal:  Int Ophthalmol       Date:  2021-01-23       Impact factor: 2.031

3.  Human oscillatory potentials: intensity-dependence of timing and amplitude.

Authors:  Heather A Hancock; Timothy W Kraft
Journal:  Doc Ophthalmol       Date:  2008-04-30       Impact factor: 2.379

4.  Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy.

Authors:  Junya Kizawa; Shigeki Machida; Takaki Kobayashi; Yasutaka Gotoh; Daijiro Kurosaka
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

5.  Assessment of early retinal changes in diabetes using a new multifocal ERG protocol.

Authors:  Y Shimada; Y Li; M A Bearse; E E Sutter; W Fung
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

6.  Electrophysiological measures of dysfunction in early-stage diabetic retinopathy: No correlation between cone phototransduction and oscillatory potential abnormalities.

Authors:  J Jason McAnany; Karen Liu; Jason C Park
Journal:  Doc Ophthalmol       Date:  2019-09-11       Impact factor: 2.379

7.  Retinal function in the von Hippel-Lindau disease.

Authors:  Wojciech Lubiński; Karol Krzystolik; Cezary Cybulski; Zbigniew Szych; Krzysztof Penkala; Olgierd Palacz; Jan Lubiński
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

8.  Oscillatory potentials of multifocal electroretinogram retinopathy.

Authors:  Hiroyuki Onozu; Shuichi Yamamoto
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

9.  The effects of early diabetes on inner retinal neurons.

Authors:  Erika D Eggers; Teresia A Carreon
Journal:  Vis Neurosci       Date:  2020-09-16       Impact factor: 3.241

10.  Permeability of the blood-ocular barrier in adolescent and adult diabetic patients.

Authors:  A Yoshida; S Ishiko; M Kojima; H Ogasawara
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.